10 Best Organ Transplant and Diagnosis Stocks To Buy Now

4. Medtronic plc (NYSE:MDT)

Market Cap as of August 1: $103.21 Billion

Hedge Funds Holding Stakes: 54

Medtronic plc (NYSE:MDT) is a medical devices company that creates, produces, and distributes medical devices and treatments to healthcare providers who also find their way into the organ transplant segment. The Cardiovascular Portfolio division specializes in developing implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices.

While Medtronic plc (NYSE:MDT) is down by about 2% for the year, it offers a solid 3.4% dividend yield, more than double the S&P 500 average of 1.4%, affirming its status as one of the 10 best organ transplant and diagnosis stocks to buy right now. As of the end of Q1 2024 a total of 54 out of 920 hedge funds tracked by Insider Monkey database held stakes in Medtronic plc (NYSE:MDT).